Render Target: SSR
Render Timestamp: 2024-10-24T19:45:26.478Z
Commit: 56767fe525c928647c8401233a175d0d607d385d
XML generation date: 2024-09-30 01:57:42.763
Product last modified at: 2024-10-10T18:00:08.557Z
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

PALB2 (E9R2W) Rabbit mAb #30253

Filter:
  • WB

    Supporting Data

    REACTIVITY H
    SENSITIVITY Endogenous
    MW (kDa) 150
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    Species Cross-Reactivity Key:
    • H-Human 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    PALB2 (E9R2W) Rabbit mAb recognizes endogenous levels of total PALB2 protein.

    Species Reactivity:

    Human

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Val213 of human PALB2 protein.

    Background

    Partner and localizer of BRCA2 (PALB2), also known as Fanconi Anemia Complementation Group N (FANCN) protein, is an essential binding partner for BRCA1 and BRCA2 proteins. PALB2 acts as a molecular scaffold for the BRCA1/BRCA2/RAD51 DNA repair complex, and functions to help recruit this complex to sites of DNA damage and stimulate RAD51 DNA strand-invasion activity required for D-loop formation (1). PALB2 is a tumor suppressor protein that is required for homologous repair of double-stranded DNA breaks. Mutations in PALB2 (mostly mono-allelic truncations) lead to increased susceptibility to breast, prostate, and pancreatic cancers (2-4). Homozygous mutation of PALB2 leads to FANCN, a disorder affecting all bone marrow elements, resulting in anemia, leukopenia, and thrombopenia (5).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.